+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Bifurcation Lesions Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Dedicated Bifurcation Stents, Balloon Dilatation Catheters, Drug-Eluting Stents , Bioresorbable Vascular Scaffolds ), By Technique Application (Provisional Stenting , Complex Stenting ), By Application Area (Coronary Vascular Interventions, Peripheral Vascular Interventions), By End-User (Hospitals & Cardiac Care Centers, Ambulatory Surgical Centers , Specialty Cardiology Clinics) Companies, and Country Forecast, 2021 to 2034

Global Bifurcation Lesions Market size is forecast to increase from $2.86 Billion in 2026 to $4.63 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005857
Pages: 226 Pages

Beta Lactam and Beta Lactamase Inhibitors Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Penicillins, Cephalosporins, Carbapenems, Monobactams, Beta-Lactamase Inhibitor Combinations), By Route of Administration (Intravenous , Oral, Others), By Indication (Respiratory Tract Infections, Urinary Tract Infections (UTIs , Skin and Soft Tissue Infections, Complicated Intra-Abdominal Infections (cIAIs), Bloodstream Infections , Nosocomial ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Providers) Companies, and Country Forecast, 2021 to 2034

Global Beta Lactam and Beta Lactamase Inhibitors Market size is forecast to increase from $32.06 Billion in 2026 to $39.99 Billion in 2034 at a CAGR of 2.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005856
Pages: 228 Pages

Benzodiazepine Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Product (Alprazolam, Diazepam, Lorazepam, Clonazepam, Midazolam, Others), By Indication (Anxiety Disorders, Insomnia , Seizures and Epilepsy, Alcohol Withdrawal, Muscle Spasms and Sedation), By Time of Action (Ultra-Short Acting, Short Acting, Intermediate Acting, Long Acting), By Route of Administration (Oral , Parenteral , Intranasal ), By Distribution Channel (Hospital Pharmacies, Retail and Community Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Benzodiazepine Drugs Market size is forecast to increase from $3.38 Billion in 2026 to $4.52 Billion in 2034 at a CAGR of 3.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005855
Pages: 213 Pages

Benign Prostatic Hyperplasia (BPH) Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Medication , Minimally Invasive Procedures, Invasive ), By Drug Class (Alpha-Blockers, 5-Alpha Reductase Inhibitors (5-ARIs), Phosphodiesterase-5 (PDE-5) Inhibitors, Combination Therapies), By Product (Resectoscopes, Urology Lasers, Prostatic Urethral Lift Systems, Water Vapor Ablation ), By End-User (Hospitals, Specialty Urology Clinics, Ambulatory Surgical Centers (ASCs)) Companies, and Country Forecast, 2021 to 2034

Global Benign Prostatic Hyperplasia (BPH) Treatment Market size is forecast to increase from $14.53 Billion in 2026 to $22.13 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005854
Pages: 210 Pages

Benign Positional Vertigo Market Size, Share and Growth Outlook, 2026: Analysis By Therapeutics (Antihistamines, Benzodiazepines, Anticholinergics, Vestibular Function Restoratives), By Type (Branded, Generic), By Route of Administration (Oral, Parenteral), By End-User (Hospitals, Specialty Clinics, Ambulatory Care Centers, Homecare Providers) Companies, and Country Forecast, 2021 to 2034

Global Benign Positional Vertigo Market size is forecast to increase from $2.03 Billion in 2026 to $2.97 Billion in 2034 at a CAGR of 4.86% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005853
Pages: 230 Pages

Bench-top Dental Autoclaves Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Automatic, Semi-Automatic, Manual), By Technology (Pre and Post Vacuum, Gravity), By Class (Class B, Class S, Class N), By End-User (Dental Clinics, Hospitals, Dental Laboratories, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Bench-top Dental Autoclaves Market size is forecast to increase from $167.81 Million in 2026 to $261.47 Million in 2034 at a CAGR of 5.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005852
Pages: 216 Pages

Benchtop Automation Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Automated Liquid Handling Systems, Robotic Systems, Sample Storage and Handling Equipment, System Accessories), By Application (Drug Discovery, Genomics, Proteomics, Clinical Diagnostics, Bioprocessing), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Diagnostic Laboratories, Environmental Testing Laboratories, Forensic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Benchtop Automation Market size is forecast to increase from $2.59 Billion in 2026 to $4.83 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005851
Pages: 223 Pages

Bench-Top Autoclave Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Pre- and Post-Vacuum , Gravity Displacement , Steam Flush Pressure Pulse ), By Chamber Capacity (Low Capacity , Medium Capacity , High Capacity ), By Technology (Automatic Bench-Top Autoclaves, Semi-Automatic Bench-Top Autoclaves, Manual Bench-Top Autoclaves), By End-User (Dental Clinics, Hospitals & Medical Centers, Research & Academic Laboratories, Tattoo & Beauty Parlors, Veterinary Clinics) Companies, and Country Forecast, 2021 to 2034

Global Bench-Top Autoclave Market size is forecast to increase from $163.01 Million in 2026 to $252.07 Million in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005850
Pages: 213 Pages

Behcet's Disease Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Corticosteroids, Immunosuppressive Agents, Biologic Therapies , PDE4 Inhibitors, Topical Agents & Ophthalmic Solutions), By Disease Manifestation (Ocular Behcet’s Disease, Mucocutaneous Behcet’s Disease, Neuro-Behcet’s Disease, Vascular Behcet’s Disease, Gastrointestinal Behcet’s Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Behcet's Disease Therapeutics Market size is forecast to increase from $1043.66 Million in 2026 to $1766.56 Million in 2034 at a CAGR of 6.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005849
Pages: 226 Pages

Behavioral Rehabilitation Market Size, Share and Growth Outlook, 2026: Analysis By Type of Behavioral Disorder (Anxiety Disorders, Mood Disorders , Substance Abuse Disorders , Personality Disorders, Eating Disorders, Attention Deficit Disorders ), By Healthcare Setting (Outpatient Programs, Inpatient Programs, Residential Rehabilitation Centers), By Treatment Method (Counselling & Psychotherapy, Medication-Assisted Treatment , Support Services & Group Therapy), By Age Group (Pediatric & Adolescent, Adults, Geriatric) Companies, and Country Forecast, 2021 to 2034

Global Behavioral Rehabilitation Market size is forecast to increase from $612.6 Billion in 2026 to $1030.73 Billion in 2034 at a CAGR of 6.72% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005848
Pages: 219 Pages